计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
M126521-5mg |
5mg |
现货 ![]() |
| |
M126521-25mg |
25mg |
现货 ![]() |
| |
M126521-50mg |
50mg |
现货 ![]() |
| |
M126521-100mg |
100mg |
现货 ![]() |
| |
M126521-250mg |
250mg |
现货 ![]() |
| |
M126521-500mg |
500mg |
现货 ![]() |
| |
M126521-1g |
1g |
期货 ![]() |
|
别名 | 蛋白酶体抑制剂 | 碳苯并-L-亮氨酰-L-亮氨酰-L-亮氨酸 |
---|---|
英文别名 | MG132 | Z-LLL-CHO | KBio3_000059 | NCGC00161679-01 | s10322 | SMR002530629 | HMS1989B12 | n-benzyloxycarbonyl-l-leucyl-l-leucyl-l-leucinal | NCGC00161679-03 | NCGC00161679-04 | Z-Leu-leu-leucinal | KBioGR_000030 | {1-[1-(1-Formyl-3-methyl-butylcarbamoyl)- |
规格或纯度 | Moligand™, ≥98% |
英文名称 | MG-132 |
生化机理 | MG-132 [Z-Leu-Leu-Leu-CHO]是一种蛋白酶体抑制剂,可用于干扰蛋白酶体调控的细胞内蛋白质降解。蛋白酶体处理的这些蛋白质参与了炎症过程和细胞周期调控,因此这类醛类蛋白酶体抑制剂具有广泛的相关性。MG-132 通过阻止 IκB 降解(IC50=3 μM)来抑制 NF-κB 激活(10 μM),从而阻止转录因子为癌细胞提供化疗抗性。它还是一种钙蛋白酶抑制剂。MG-132 [Z-Leu-Leu-Leu-CHO] 是 26S 蛋白酶体的抑制剂,也是 JNK1、c-Jun 和 c-Fos 的激活剂。 |
储存温度 | -20°C储存 |
运输条件 | 超低温冰袋运输 |
备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,这些产品最多可以使用一周。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
产品介绍 |
MG-132是一种蛋白酶体抑制剂,IC50为100 nM,也抑制钙蛋白酶,IC50为1.2 μM。A proteasome and NF-κB inhibitor. MG-132 is an inhibitor of proteasome with IC50 of 100 nM, and also inhibits calpain with IC50 of 1.2 μM. |
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
分子类型 | 蛋白质 |
---|---|
IUPAC Name | benzyl N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate |
INCHI | InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1 |
InChi Key | TZYWCYJVHRLUCT-VABKMULXSA-N |
Canonical SMILES | CC(C)CC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCC1=CC=CC=C1 |
Isomeric SMILES | CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1 |
PubChem CID | 462382 |
分子量 | 475.62 |
溶解性 | Soluble in DMSO (25 mg/ml), 100% ethanol (25 mg/ml), chloroform:methanol solution (95:5) (10 mg/ml), water (<1 mg/ml), and DMF (~25 mg/ml). |
---|---|
敏感性 | 对热敏感 |
分子量 | 475.600 g/mol |
XLogP3 | 4.800 |
氢键供体数Hydrogen Bond Donor Count | 3 |
氢键受体数Hydrogen Bond Acceptor Count | 5 |
可旋转键计数Rotatable Bond Count | 15 |
精确质量Exact Mass | 475.305 Da |
单同位素质量Monoisotopic Mass | 475.305 Da |
拓扑极表面积Topological Polar Surface Area | 114.000 Ų |
重原子数Heavy Atom Count | 34 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 644.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 3 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
Appearance(M126521) | White to Yellow Solid |
---|---|
Proton NMR spectrum | Conforms to Structure |
Solubility in DMSO,Colorless to Faint Yellow Clear(9.80-10.20 mg/ml) | Conforms |
LC-MS for identification | Conforms |
Purity(NMR) | 98-100(%) |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
批号(Lot Number) | 证书类型 | 日期 | 货号 |
---|---|---|---|
![]() |
分析证书 | 25-05-10 | M126521 |
![]() |
分析证书 | 25-04-08 | M126521 |
![]() |
分析证书 | 25-04-08 | M126521 |
![]() |
分析证书 | 24-12-28 | M126521 |
![]() |
分析证书 | 24-07-12 | M126521 |
![]() |
分析证书 | 24-07-12 | M126521 |
![]() |
分析证书 | 24-07-12 | M126521 |
![]() |
分析证书 | 24-07-12 | M126521 |
![]() |
分析证书 | 24-07-12 | M126521 |
![]() |
分析证书 | 23-10-07 | M126521 |
![]() |
分析证书 | 23-10-07 | M126521 |
![]() |
分析证书 | 23-10-07 | M126521 |
![]() |
分析证书 | 23-02-09 | M126521 |
![]() |
分析证书 | 22-09-19 | M126521 |
![]() |
分析证书 | 22-09-08 | M126521 |
![]() |
分析证书 | 22-09-08 | M126521 |
![]() |
分析证书 | 22-06-27 | M126521 |
![]() |
分析证书 | 22-06-27 | M126521 |
![]() |
分析证书 | 21-11-25 | M126521 |
![]() |
分析证书 | 21-11-25 | M126521 |
1. Dai Bing, Liu Si, Shen Wenxin, Chen Li, Zhou Qianlan, Han Lina, Zhang Qinzhen, Shan Lishen. (2023) Role of SYVN1 in the control of airway remodeling in asthma protection by promoting SIRT2 ubiquitination and degradation. BIOLOGICAL RESEARCH, 56 (1): (1-14). [PMID:38041162] [10.1186/s40659-023-00478-7] |
2. Xiaojing Xing, Meichen Liu, Xuguang Wang, Qianxue Guo, Hongyue Wang, Wenxue Wang. (2023) FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, (3): [PMID:37987202] [10.1111/jcmm.18041] |
3. Haoze Song, Jing Liang, Yuanyuan Guo, Yang Liu, Kuiru Sa, Guohong Yan, Wen Xu, Wei Xu, Lixia Chen, Hua Li. (2024) A potent GPX4 degrader to induce ferroptosis in HT1080 cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 265 (116110). [PMID:38194774] [10.1016/j.ejmech.2023.116110] |
4. Lei Ming, Lin Hui, Shi Deyao, Hong Pan, Song Hui, Herman Bomansaan, Liao Zhiwei, Yang Cao. (2023) Molecular mechanism and therapeutic potential of HDAC9 in intervertebral disc degeneration. CELLULAR & MOLECULAR BIOLOGY LETTERS, 28 (1): (1-24). [PMID:38093179] [10.1186/s11658-023-00517-x] |
5. Yanping Fan, Meilan Xue, Tianhu Shan, Yixian Bai, Huaqi Zhang, Man Liu, Peng Wang, Xi Liang, Hui Liang. (2024) Niacin alleviates extracellular matrix deposition in ethanol + CCl4-induced liver fibrosis through the HSP90/JAK1/STAT3 axis. Food Bioscience, 57 (103454). [10.1016/j.fbio.2023.103454] |
6. Haiyan Zhao, Fangfang Bi, Mengyuan Li, Yuhan Diao, Chen Zhang. (2024) E3 ubiquitin ligase RNF180 impairs IPO4/SOX2 complex stability and inhibits SOX2-mediated malignancy in ovarian cancer. CELLULAR SIGNALLING, 113 (110961). [PMID:37923100] [10.1016/j.cellsig.2023.110961] |
7. Ye Jianfeng, Liu Wangmin, Yu Xueyang, Wu Lina, Chen Zhengjie, Yu Yufei, Wang Jianfeng, Bai Song, Zhang Mo. (2023) TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling. Cell Death Discovery, 9 (1): (1-15). [PMID:37845209] [10.1038/s41420-023-01675-9] |
8. Xing Zeyu, Zhen Yanhua, Chen Jie, Du Mingyang, Li Dongdong, Liu Ruyin, Zheng Jiahe. (2023) KPNA2 Silencing, Regulated by E3 Ubiquitin Ligase FBXW7, Alleviates Endothelial Dysfunction and Inflammation Through Inhibiting the Nuclear Translocation of p65 and IRF3: A Possible Therapeutic Approach for Atherosclerosis. INFLAMMATION, (1-18). [PMID:37432596] [10.1007/s10753-023-01863-w] |
9. Xin Wu, Xin Zhang, Peng Liu, Yao Wang. (2023) Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6. PANCREATOLOGY, [PMID:37460341] [10.1016/j.pan.2023.06.011] |
10. Heyang Zhang, Yuan Tao, Xin Ding, Yue Wang, Xiaoxue Wang. (2023) Roles of the hsa_circ_0013880/USP32/Rap1b axis in the proliferation and apoptosis of acute myeloid leukemia cells: hsa_circ_0013880/USP32/Rap1b in acute myeloid leukemia. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 55 (3): ( 382–393). [PMID:36951484] [10.3724/abbs.2023037] |
11. Jiahong Guo, Wenji Huang, Xin Zhao, Ning Ji, Kangyong Chen, Yanjie Shi, Jianhua Feng, Jun Zou, Junya Wang. (2023) The expanded ISG12 family in zebrafish: ISG12.1 suppresses virus replication via targeting viral phosphoprotein. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 142 (104672). [PMID:36822549] [10.1016/j.dci.2023.104672] |
12. Rui Yu, Yan Wu, Ping He, Yu Bai, Yongzhe Zhang, Xiaohui Bian, Guangping Sun, Beiru Zhang. (2023) LIM and Cysteine-Rich Domains 1 Promotes Transforming Growth Factor β1–Induced Epithelial–Mesenchymal Transition in Human Kidney 2 Cells. LABORATORY INVESTIGATION, 103 (100016). [PMID:37039151] [10.1016/j.labinv.2022.100016] |
13. Dingyou Wang, Yuke Ji, Rui Wang, Ke Cheng, Liang Liu, Na Wu, Qing Tang, Xu Zheng, Junxia Li, Zhilong Zhu, Qinghua Wang, Xueyan Zhang, Runbo Li, Jinjin Pan, Zheng Sui, Yuhui Yuan. (2022) Lycopene Ameliorates Hypoxic Pulmonary Hypertension via Suppression of Oxidative Stress. Oxidative Medicine and Cellular Longevity, 2022 (9179427). [10.1155/2022/9179427] |
14. Xue-qi Liu, Ming-ming Liu, Ling Jiang, Li Gao, Yao Zhang, Yue-bo Huang, Xian Wang, Wei Zhu, Han-xu Zeng, Xiao-ming Meng, Yong-gui Wu. (2022) A novel small molecule Hsp90 inhibitor, C-316-1, attenuates acute kidney injury by suppressing RIPK1-mediated inflammation and necroptosis. INTERNATIONAL IMMUNOPHARMACOLOGY, 108 (108849). [PMID:35588657] [10.1016/j.intimp.2022.108849] |
15. Bai Shuju, Wang Wenbo, Zhang Zhiwei, Li Mengyao, Chen Zehan, Wang Jiuqiao, Zhao Yanlin, An Lu, Wang Yuxiang, Xing Shu, Fu Xueqi, Ma Junfeng. (2021) Ethanol Alleviates Amyloid-β-Induced Toxicity in an Alzheimer’s Disease Model of Caenorhabiditis elegans. Frontiers in Aging Neuroscience, 13 [PMID:34867289] [10.3389/fnagi.2021.762659] |
16. Zhang Qi, Li Danyang, Dong Xue, Zhang Xiaowen, Liu Junwu, Peng Lili, Meng Bo, Hua Qi, Pei Xinyu, Zhao Lu, Hu Xiaoxi, Zhang Yang, Pan Zhenwei, Lu Yanjie, Yang Baofeng. (2022) LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathy. Science China-Life Sciences, 65 (6): (1198-1212). [PMID:34668131] [10.1007/s11427-021-1982-8] |
17. Tan Peng, Xu Yunke, Du Yichao, Wu Lile, Guo Bing, Huang Shiyao, Zhu Jinhui, Li Bo, Lin Fujun, Yao Lei. (2019) SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Cell Death & Disease, 10 (11): (1-16). [PMID:31624231] [10.1038/s41419-019-2017-z] |
18. Wenjing Li, Zulin Wu, Yongheng Liang. (2019) Vrl1 relies on its VPS9-domain to play a role in autophagy in Saccharomyces cerevisiae. CELL BIOLOGY INTERNATIONAL, 43 (8): (875-889). [PMID:31038239] [10.1002/cbin.11156] |
19. Niu Xiuran, Su Linjia, Qi Shanshan, Gao Zhihui, Zhang Qing, Zhang Sihe. (2018) GRP75 modulates oncogenic Dbl-driven endocytosis derailed via the CHIP-mediated ubiquitin degradation pathway. Cell Death & Disease, 9 (10): (1-16). [PMID:30250167] [10.1038/s41419-018-1039-2] |
20. Bowen Sun,Xifan Wang,Xiaoxue Liu,Longjiao Wang,Fazheng Ren,Xiaoyu Wang,Xiaojing Leng. (2020-08-29) Hippuric Acid Promotes Renal Fibrosis by Disrupting Redox Homeostasis via Facilitation of NRF2-KEAP1-CUL3 Interactions in Chronic Kidney Disease.. Antioxidants (Basel, Switzerland), 9 ((9)): [PMID:32854194] |
1. Xu S et al.. (2019) Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer.. Mol Cancer, 18 (89). [PMID:30999914] |
2. Xu C et al.. (2021) ATE1 Inhibits Liver Cancer Progression through RGS5-Mediated Suppression of Wnt/ß-Catenin Signaling.. Mol Cancer Res, 19 (9): (1441-1453). [PMID:34158395] |
3. Zhao X et al.. (2020) Camptothecin induced DDX5 degradation increased the camptothecin resistance of osteosarcoma.. Exp Cell Res, 394 (2): (112148). [PMID:32585151] |
4. Venard CM et al.. (2020) Cilium axoneme internalization and degradation in chytrid fungi.. Cytoskeleton (Hoboken), 77 (10): (365-378). [PMID:33103844] |
5. Rippin I et al.. (2020) Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site.. Int J Mol Sci, 21 (22): [PMID:33218072] |
6. Baarsma HA et al.. (2020) Disruption of AKAP-PKA Interaction Induces Hypercontractility With Concomitant Increase in Proliferation Markers in Human Airway Smooth Muscle.. Front Cell Dev Biol, 8 (165). [PMID:32328490] |
7. Liu X et al.. (2016) HSP90 inhibits apoptosis and promotes growth by regulating HIF-1a abundance in hepatocellular carcinoma.. Int J Mol Med, 37 (3): (825-35). [PMID:26846697] |
8. Xu Q et al.. (2017) HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.. Mol Cancer, 16 (178). [PMID:29262861] |
9. Jimenez-Guardeño JM et al.. (2019) Immunoproteasome activation enables human TRIM5a restriction of HIV-1.. Nat Microbiol, 4 (6): (933-940). [PMID:30886358] |
10. Luciani A et al.. (2020) Impaired mitophagy links mitochondrial disease to epithelial stress in methylmalonyl-CoA mutase deficiency.. Nat Commun, 11 (970). [PMID:32080200] |
11. Simpson LM et al.. (2020) Inducible Degradation of Target Proteins through a Tractable Affinity-Directed Protein Missile System.. Cell Chem Biol, 27 (9): (1164-1180.e5). [PMID:32668203] |
12. Chen L et al.. (2020) Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma.. J Cell Mol Med, 24 (9): (5387-5401). [PMID:32237037] |
13. Kumar Singh R et al.. (2021) KSHV-encoded vCyclin can modulate HIF1a levels to promote DNA replication in hypoxia.. Elife, 10 [PMID:34279223] |
14. Saha S et al.. (2021) Leishmania donovani Targets Host Transcription Factor NRF2 To Activate Antioxidant Enzyme HO-1 and Transcriptional Repressor ATF3 for Establishing Infection.. Infect Immun, 89 (7): (e0076420). [PMID:33820818] |
15. Cheng J et al.. (2016) MEK1 signaling promotes self-renewal and tumorigenicity of liver cancer stem cells via maintaining SIRT1 protein stabilization.. Oncotarget, 7 (15): (20597-611). [PMID:26967560] |
16. Robu M et al.. (2020) Methods to Study Intracellular Movement and Localization of the Nucleotide Excision Repair Proteins at the DNA Lesions in Mammalian Cells.. Front Cell Dev Biol, 8 (590242). [PMID:33282869] |
17. Huang Y et al.. (2021) miR-19b enhances osteogenic differentiation of mesenchymal stem cells and promotes fracture healing through the WWP1/Smurf2-mediated KLF5/ß-catenin signaling pathway.. Exp Mol Med, 53 (5): (973-985). [PMID:34035464] |
18. Zhang H et al.. (2017) Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma.. Oncotarget, 8 (21): (34362-34373). [PMID:28416766] |
19. Wang S et al.. (2020) Overexpression of RNF126 Promotes the Development of Colorectal Cancer via Enhancing p53 Ubiquitination and Degradation.. Onco Targets Ther, 13 (10917-10929). [PMID:33149608] |
20. Chen K et al.. (2020) Parkin ubiquitinates GATA4 and attenuates the GATA4/GAS1 signaling and detrimental effects on diabetic nephropathy.. FASEB J, 34 (7): (8858-8875). [PMID:32436607] |
21. Stevenson TJ et al.. (2022) Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress.. Sci Rep, 12 (17314). [PMID:36243723] |
22. Walton CC et al.. (2019) Primary neurons can enter M-phase.. Sci Rep, 9 (4594). [PMID:30872646] |
23. Gain C et al.. (2020) Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.. PLoS Pathog, 16 (2): (e1008105). [PMID:32092124] |
24. Rai M et al.. (2021) Proteasome stress in skeletal muscle mounts a long-range protective response that delays retinal and brain aging.. Cell Metab, 33 (6): (1137-1154.e9). [PMID:33773104] |
25. Soday L et al.. (2019) Quantitative Temporal Proteomic Analysis of Vaccinia Virus Infection Reveals Regulation of Histone Deacetylases by an Interferon Antagonist.. Cell Rep, 27 (6): (1920-1933.e7). [PMID:31067474] |
26. Feng D et al.. (2021) Regulation of Wnt/PCP signaling through p97/VCP-KBTBD7-mediated Vangl ubiquitination and endoplasmic reticulum-associated degradation.. Sci Adv, 7 (20): [PMID:33990333] |
27. Lee MJ et al.. (2022) SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D.. Cell Rep, 41 (13): (111892). [PMID:36543165] |
28. Bresque M et al.. (2022) SIRT6 stabilization and cytoplasmic localization in macrophages regulates acute and chronic inflammation in mice.. J Biol Chem, 298 (3): (101711). [PMID:35150745] |
29. Röth S et al.. (2020) Targeting Endogenous K-RAS for Degradation through the Affinity-Directed Protein Missile System.. Cell Chem Biol, 27 (9): (1151-1163.e6). [PMID:32668202] |
30. Yang L et al.. (2022) TGFBR2 is a novel substrate and indirect transcription target of deubiquitylase USP9X in granulosa cells.. J Cell Physiol, 237 (7): (2969-2979). [PMID:35578792] |
31. Coricor G & Serra R. (2016) TGF-ß regulates phosphorylation and stabilization of Sox9 protein in chondrocytes through p38 and Smad dependent mechanisms.. Sci Rep, 6 (38616). [PMID:27929080] |
32. Huang W et al.. (2022) USP5 promotes breast cancer cell proliferation and metastasis by stabilizing HIF2α.. J Cell Physiol, 237 (4): (2211-2219). [PMID:35102545] |
33. Dai Bing, Liu Si, Shen Wenxin, Chen Li, Zhou Qianlan, Han Lina, Zhang Qinzhen, Shan Lishen. (2023) Role of SYVN1 in the control of airway remodeling in asthma protection by promoting SIRT2 ubiquitination and degradation. BIOLOGICAL RESEARCH, 56 (1): (1-14). [PMID:38041162] [10.1186/s40659-023-00478-7] |
34. Xiaojing Xing, Meichen Liu, Xuguang Wang, Qianxue Guo, Hongyue Wang, Wenxue Wang. (2023) FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, (3): [PMID:37987202] [10.1111/jcmm.18041] |
35. Haoze Song, Jing Liang, Yuanyuan Guo, Yang Liu, Kuiru Sa, Guohong Yan, Wen Xu, Wei Xu, Lixia Chen, Hua Li. (2024) A potent GPX4 degrader to induce ferroptosis in HT1080 cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 265 (116110). [PMID:38194774] [10.1016/j.ejmech.2023.116110] |
36. Lei Ming, Lin Hui, Shi Deyao, Hong Pan, Song Hui, Herman Bomansaan, Liao Zhiwei, Yang Cao. (2023) Molecular mechanism and therapeutic potential of HDAC9 in intervertebral disc degeneration. CELLULAR & MOLECULAR BIOLOGY LETTERS, 28 (1): (1-24). [PMID:38093179] [10.1186/s11658-023-00517-x] |
37. Yanping Fan, Meilan Xue, Tianhu Shan, Yixian Bai, Huaqi Zhang, Man Liu, Peng Wang, Xi Liang, Hui Liang. (2024) Niacin alleviates extracellular matrix deposition in ethanol + CCl4-induced liver fibrosis through the HSP90/JAK1/STAT3 axis. Food Bioscience, 57 (103454). [10.1016/j.fbio.2023.103454] |
38. Haiyan Zhao, Fangfang Bi, Mengyuan Li, Yuhan Diao, Chen Zhang. (2024) E3 ubiquitin ligase RNF180 impairs IPO4/SOX2 complex stability and inhibits SOX2-mediated malignancy in ovarian cancer. CELLULAR SIGNALLING, 113 (110961). [PMID:37923100] [10.1016/j.cellsig.2023.110961] |
39. Ye Jianfeng, Liu Wangmin, Yu Xueyang, Wu Lina, Chen Zhengjie, Yu Yufei, Wang Jianfeng, Bai Song, Zhang Mo. (2023) TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling. Cell Death Discovery, 9 (1): (1-15). [PMID:37845209] [10.1038/s41420-023-01675-9] |
40. Xing Zeyu, Zhen Yanhua, Chen Jie, Du Mingyang, Li Dongdong, Liu Ruyin, Zheng Jiahe. (2023) KPNA2 Silencing, Regulated by E3 Ubiquitin Ligase FBXW7, Alleviates Endothelial Dysfunction and Inflammation Through Inhibiting the Nuclear Translocation of p65 and IRF3: A Possible Therapeutic Approach for Atherosclerosis. INFLAMMATION, (1-18). [PMID:37432596] [10.1007/s10753-023-01863-w] |
41. Xin Wu, Xin Zhang, Peng Liu, Yao Wang. (2023) Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6. PANCREATOLOGY, [PMID:37460341] [10.1016/j.pan.2023.06.011] |
42. Heyang Zhang, Yuan Tao, Xin Ding, Yue Wang, Xiaoxue Wang. (2023) Roles of the hsa_circ_0013880/USP32/Rap1b axis in the proliferation and apoptosis of acute myeloid leukemia cells: hsa_circ_0013880/USP32/Rap1b in acute myeloid leukemia. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 55 (3): ( 382–393). [PMID:36951484] [10.3724/abbs.2023037] |
43. Jiahong Guo, Wenji Huang, Xin Zhao, Ning Ji, Kangyong Chen, Yanjie Shi, Jianhua Feng, Jun Zou, Junya Wang. (2023) The expanded ISG12 family in zebrafish: ISG12.1 suppresses virus replication via targeting viral phosphoprotein. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 142 (104672). [PMID:36822549] [10.1016/j.dci.2023.104672] |
44. Rui Yu, Yan Wu, Ping He, Yu Bai, Yongzhe Zhang, Xiaohui Bian, Guangping Sun, Beiru Zhang. (2023) LIM and Cysteine-Rich Domains 1 Promotes Transforming Growth Factor β1–Induced Epithelial–Mesenchymal Transition in Human Kidney 2 Cells. LABORATORY INVESTIGATION, 103 (100016). [PMID:37039151] [10.1016/j.labinv.2022.100016] |
45. Dingyou Wang, Yuke Ji, Rui Wang, Ke Cheng, Liang Liu, Na Wu, Qing Tang, Xu Zheng, Junxia Li, Zhilong Zhu, Qinghua Wang, Xueyan Zhang, Runbo Li, Jinjin Pan, Zheng Sui, Yuhui Yuan. (2022) Lycopene Ameliorates Hypoxic Pulmonary Hypertension via Suppression of Oxidative Stress. Oxidative Medicine and Cellular Longevity, 2022 (9179427). [10.1155/2022/9179427] |
46. Xue-qi Liu, Ming-ming Liu, Ling Jiang, Li Gao, Yao Zhang, Yue-bo Huang, Xian Wang, Wei Zhu, Han-xu Zeng, Xiao-ming Meng, Yong-gui Wu. (2022) A novel small molecule Hsp90 inhibitor, C-316-1, attenuates acute kidney injury by suppressing RIPK1-mediated inflammation and necroptosis. INTERNATIONAL IMMUNOPHARMACOLOGY, 108 (108849). [PMID:35588657] [10.1016/j.intimp.2022.108849] |
47. Bai Shuju, Wang Wenbo, Zhang Zhiwei, Li Mengyao, Chen Zehan, Wang Jiuqiao, Zhao Yanlin, An Lu, Wang Yuxiang, Xing Shu, Fu Xueqi, Ma Junfeng. (2021) Ethanol Alleviates Amyloid-β-Induced Toxicity in an Alzheimer’s Disease Model of Caenorhabiditis elegans. Frontiers in Aging Neuroscience, 13 [PMID:34867289] [10.3389/fnagi.2021.762659] |
48. Zhang Qi, Li Danyang, Dong Xue, Zhang Xiaowen, Liu Junwu, Peng Lili, Meng Bo, Hua Qi, Pei Xinyu, Zhao Lu, Hu Xiaoxi, Zhang Yang, Pan Zhenwei, Lu Yanjie, Yang Baofeng. (2022) LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathy. Science China-Life Sciences, 65 (6): (1198-1212). [PMID:34668131] [10.1007/s11427-021-1982-8] |
49. Tan Peng, Xu Yunke, Du Yichao, Wu Lile, Guo Bing, Huang Shiyao, Zhu Jinhui, Li Bo, Lin Fujun, Yao Lei. (2019) SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Cell Death & Disease, 10 (11): (1-16). [PMID:31624231] [10.1038/s41419-019-2017-z] |
50. Wenjing Li, Zulin Wu, Yongheng Liang. (2019) Vrl1 relies on its VPS9-domain to play a role in autophagy in Saccharomyces cerevisiae. CELL BIOLOGY INTERNATIONAL, 43 (8): (875-889). [PMID:31038239] [10.1002/cbin.11156] |
51. Niu Xiuran, Su Linjia, Qi Shanshan, Gao Zhihui, Zhang Qing, Zhang Sihe. (2018) GRP75 modulates oncogenic Dbl-driven endocytosis derailed via the CHIP-mediated ubiquitin degradation pathway. Cell Death & Disease, 9 (10): (1-16). [PMID:30250167] [10.1038/s41419-018-1039-2] |
52. Bowen Sun,Xifan Wang,Xiaoxue Liu,Longjiao Wang,Fazheng Ren,Xiaoyu Wang,Xiaojing Leng. (2020-08-29) Hippuric Acid Promotes Renal Fibrosis by Disrupting Redox Homeostasis via Facilitation of NRF2-KEAP1-CUL3 Interactions in Chronic Kidney Disease.. Antioxidants (Basel, Switzerland), 9 ((9)): [PMID:32854194] |